Browsing by Author Gazi, I.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 14 to 25 of 25 < previous 
TitleAuthor(s)Issue date???itemlist.???
LDL cholesterol estimation in patients with the metabolic syndromeGazi, I.; Tsimihodimos, V.; Filippatos, T. D.; Saougos, V. G.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
LDL subfractions in patients with metabolic syndromeGazi, I.; Filippatos, T.; Bairaktari, E.; Kostara, C.; Tselepis, A.; Elisaf, M. S.24-Nov-2015-
Lipid Profile and Serum Levels of Markers of Inflammation in Patients with Acute BrucellosisApostolou, F.; Gazi, I.; Tselepis, A.; Elisaf, M.; Liberopoulos, E.24-Nov-2015-
Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndromeRizos, E.; Tambaki, A. P.; Gazi, I.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Lipoprotein-associated phospholipase A(2) activity is a marker of small, dense LDL particles in human plasmaGazi, I.; Lourida, E. S.; Filippatos, T.; Tsimihodimos, V.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Lipoprotein-associated phospholipase A2 activity (LP-PLA2) is a marker of small-dense LDL particlesGazi, I.; Lourida, E.; Filippatos, T.; Tsimihodimos, V.; Saougos, V.; Elisaf, M.; Tselepis, A.24-Nov-2015-
Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particlesTsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Plasma PAF-acetylhydrolase(Lp-PLA(2)) activity as a marker of small-dense LDL in subjects at median cardiovascular riskFilippatos, T. D.; Gazi, I.; Kiortsis, D. N.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Plasma triglyceride levels and body mass index values are the most important determinants of pre beta-1 HDL concentrations in patients with various types of primary dyslipidemiaTsimihodimos, V.; Gazi, I.; Filippatos, T.; Kostapanos, M.; Lagos, K.; Kostara, C.; Tellis, C. C.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Quantitative and qualitative changes of serum lipoproteins in patients with acute brucellosisApostolou, F.; Liberoloulos, E.; Gazi, I.; Tsouli, S.; Tsianos, E.; Tselepis, A.; Elisaf, M. S.24-Nov-2015-
Rosuvastatin administration decreases apolipoprotein CII and CIII serum levels in patients with primary dysilipidaemiaKostapanos, M.; Filippatos, T.; Gazi, I.; Saougos, V. G.; Milionis, H. J.; Kostara, C.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemiaKostapanos, M. S.; Milionis, H. J.; Gazi, I.; Kostara, C.; Bairaktari, E. T.; Elisaf, M. S.24-Nov-2015-